Oncological safety of minimally invasive surgery in borderline ovarian tumor and ovarian cancer: a retrospective comparative study
Laparoscopic surgery for borderline ovarian tumors is suggested to be oncologically safe, with low recurrence rate and no adverse impact on survival. However, for ovarian cancer, particularly in cases with peritoneal dissemination, rapid disease progression remains a concern. While this study suggests that laparoscopic surgery may be a viable option for borderline ovarian tumors, further research is needed to validate these findings, particularly for ovarian cancer.
Authors
- Kenro Chikazawa (ORCID: https://orcid.org/0000-0002-8839-4483)
- Ken Imai (ORCID: https://orcid.org/0000-0002-7593-7960)
- Tomoyuki Kuwata (ORCID: https://orcid.org/0000-0002-9334-6670)
- Ryo Konno (ORCID: https://orcid.org/0000-0002-9403-1339)
- N Osawa
- Hiroyoshi Ko (ORCID: https://orcid.org/0009-0004-5009-8963)
Institutions
- Jichi Medical University (JP)
- Jichi Medical University Saitama Medical Center (JP)
Publication Details
- Journal
- Journal of Gynecologic Oncology
- Published
- 2024-11-19
- DOI
- https://doi.org/10.3802/jgo.2025.36.e46
- Citations
- 1
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.54
Funders
- AstraZeneca
- Terumo
- Chugai Pharmaceutical
- Ethicon